249 related articles for article (PubMed ID: 19402861)
1. Methotrexate: long-term safety and efficacy in an Australian consultant rheumatology practice.
Varatharajan N; Lim IG; Anandacoomarasamy A; Russo R; Byth K; Spencer DG; Manolios N; Howe GB
Intern Med J; 2009 Apr; 39(4):228-36. PubMed ID: 19402861
[TBL] [Abstract][Full Text] [Related]
2. Methotrexate treatment in rheumatoid arthritis and elevated liver enzymes: A long-term follow-up of predictors, surveillance, and outcome in clinical practice.
Karlsson Sundbaum J; Eriksson N; Hallberg P; Lehto N; Wadelius M; Baecklund E
Int J Rheum Dis; 2019 Jul; 22(7):1226-1232. PubMed ID: 31012257
[TBL] [Abstract][Full Text] [Related]
3. Time to methotrexate treatment in patients with rheumatoid arthritis referred to hospital.
de Thurah A; Nørgaard M; Johansen M; Stengaard-Pedersen K
Scand J Rheumatol; 2010; 39(1):19-25. PubMed ID: 20132066
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness, tolerability, and safety of subcutaneous methotrexate in early rheumatoid arthritis: A retrospective analysis of real-world data from the St. Gallen cohort.
Müller RB; von Kempis J; Haile SR; Schiff MH
Semin Arthritis Rheum; 2015 Aug; 45(1):28-34. PubMed ID: 25895697
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness and retention rates of methotrexate in psoriatic arthritis in comparison with methotrexate-treated patients with rheumatoid arthritis.
Lie E; van der Heijde D; Uhlig T; Heiberg MS; Koldingsnes W; Rødevand E; Kaufmann C; Mikkelsen K; Kvien TK
Ann Rheum Dis; 2010 Apr; 69(4):671-6. PubMed ID: 19740904
[TBL] [Abstract][Full Text] [Related]
6. Longterm methotrexate use in rheumatoid arthritis: 12 year followup of 460 patients treated in community practice.
Wluka A; Buchbinder R; Mylvaganam A; Hall S; Harkness A; Lewis D; Littlejohn GO; Miller MH; Ryan PF
J Rheumatol; 2000 Aug; 27(8):1864-71. PubMed ID: 10955325
[TBL] [Abstract][Full Text] [Related]
7. Adverse events and factors associated with toxicity in patients with early rheumatoid arthritis treated with methotrexate tight control therapy: the CAMERA study.
Verstappen SM; Bakker MF; Heurkens AH; van der Veen MJ; Kruize AA; Geurts MA; Bijlsma JW; Jacobs JW;
Ann Rheum Dis; 2010 Jun; 69(6):1044-8. PubMed ID: 19581281
[TBL] [Abstract][Full Text] [Related]
8. Hepatotoxicity rates do not differ in patients with rheumatoid arthritis and psoriasis treated with methotrexate.
Amital H; Arnson Y; Chodick G; Shalev V
Rheumatology (Oxford); 2009 Sep; 48(9):1107-10. PubMed ID: 19578136
[TBL] [Abstract][Full Text] [Related]
9. Limitations of clinical trials in chronic diseases: is the efficacy of methotrexate (MTX) underestimated in polyarticular psoriatic arthritis on the basis of limitations of clinical trials more than on limitations of MTX, as was seen in rheumatoid arthritis?
Pincus T; Bergman MJ; Yazici Y
Clin Exp Rheumatol; 2015; 33(5 Suppl 93):S82-93. PubMed ID: 26472658
[TBL] [Abstract][Full Text] [Related]
10. Longterm retention rate and risk factor for discontinuation due to insufficient efficacy and adverse events in Japanese patients with rheumatoid arthritis receiving etanercept therapy.
Matsubara H; Kojima T; Kaneko A; Hirano Y; Ishikawa H; Hattori Y; Miyake H; Oguchi T; Takagi H; Yabe Y; Kato T; Ito T; Fukaya N; Kanayama Y; Shioura T; Hayashi M; Fujibayashi T; Takahashi N; Funahashi K; Kato D; Hanabayashi M; Terabe K; Ishiguro N
J Rheumatol; 2014 Aug; 41(8):1583-9. PubMed ID: 25028370
[TBL] [Abstract][Full Text] [Related]
11. Methotrexate therapy in rheumatoid arthritis: a life table review of 587 patients treated in community practice.
Buchbinder R; Hall S; Sambrook PN; Champion GD; Harkness A; Lewis D; Littlejohn GO; Miller MH; Ryan PF
J Rheumatol; 1993 Apr; 20(4):639-44. PubMed ID: 8496857
[TBL] [Abstract][Full Text] [Related]
12. Adverse effects of low dose methotrexate therapy in rheumatoid arthritis.
McKendry RJ; Dale P
J Rheumatol; 1993 Nov; 20(11):1850-6. PubMed ID: 8308769
[TBL] [Abstract][Full Text] [Related]
13. Long-term continuation of methotrexate therapy in giant cell arteritis patients in clinical practice.
Leon L; Rodriguez-Rodriguez L; Freites D; Arietti L; Morado I; Vadillo C; Lamas JR; Fernandez B; Jover JA; Abasolo L
Clin Exp Rheumatol; 2017; 35 Suppl 103(1):165-170. PubMed ID: 28134073
[TBL] [Abstract][Full Text] [Related]
14. Comparison of two schedules for administering oral low-dose methotrexate (weekly versus every-other-week) in patients with rheumatoid arthritis in remission: a twenty-four week, single blind, randomized study.
Luis M; Pacheco-Tena C; Cazarín-Barrientos J; Lino-Pérez L; Goycochea MV; Vazquez-Mellado J; Burgos-Vargas R
Arthritis Rheum; 1999 Oct; 42(10):2160-5. PubMed ID: 10524688
[TBL] [Abstract][Full Text] [Related]
15. Non-alcoholic steatohepatitis-like pattern in liver biopsy of rheumatoid arthritis patients with persistent transaminitis during low-dose methotrexate treatment.
Mori S; Arima N; Ito M; Fujiyama S; Kamo Y; Ueki Y
PLoS One; 2018; 13(8):e0203084. PubMed ID: 30142184
[TBL] [Abstract][Full Text] [Related]
16. [Long-term follow-up of the efficacy of methotrexate alone or in combination with low doses of oral corticosteroids in the treatment of alopecia areata totalis or universalis].
Chartaux E; Joly P
Ann Dermatol Venereol; 2010; 137(8-9):507-13. PubMed ID: 20804893
[TBL] [Abstract][Full Text] [Related]
17. Long term efficacy and safety of adalimumab plus methotrexate in patients with rheumatoid arthritis: ARMADA 4 year extended study.
Weinblatt ME; Keystone EC; Furst DE; Kavanaugh AF; Chartash EK; Segurado OG
Ann Rheum Dis; 2006 Jun; 65(6):753-9. PubMed ID: 16308341
[TBL] [Abstract][Full Text] [Related]
18. Safety and retention of combination triple disease-modifying anti-rheumatic drugs in new-onset rheumatoid arthritis.
Cummins L; Katikireddi VS; Shankaranarayana S; Su KY; Duggan E; Videm V; Pahau H; Thomas R
Intern Med J; 2015 Dec; 45(12):1266-73. PubMed ID: 26384029
[TBL] [Abstract][Full Text] [Related]
19. Leflunomide, a new disease-modifying drug for treating active rheumatoid arthritis in methotrexate-controlled phase II clinical trial.
Bao C; Chen S; Gu Y; Lao Z; Ni L; Yu Q; Xu J; Li X; Liu J; Sun L; He P; Ma J; Xu S; Ding C
Chin Med J (Engl); 2003 Aug; 116(8):1228-34. PubMed ID: 12935395
[TBL] [Abstract][Full Text] [Related]
20. Perceptions of methotrexate use in rheumatoid arthritis by rheumatologists and their patients: an Australian survey study.
Nash P; Nicholls D
Int J Rheum Dis; 2013 Dec; 16(6):652-61. PubMed ID: 24382276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
